Lessons from 20 years with COX-2 inhibitors: Importance of dose-response considerations and fair play in comparative trials.

MLA

Stiller, Carl-Olav, and Paul Hjemdahl. “Lessons from 20 Years with COX-2 Inhibitors: Importance of Dose-Response Considerations and Fair Play in Comparative Trials.” Journal of Internal Medicine, vol. 292, no. 4, Oct. 2022, pp. 557–74. EBSCOhost, https://doi.org/10.1111/joim.13505.

APA

Stiller, C.-O., & Hjemdahl, P. (2022). Lessons from 20 years with COX-2 inhibitors: Importance of dose-response considerations and fair play in comparative trials. Journal of Internal Medicine, 292(4), 557–574. https://doi.org/10.1111/joim.13505

Chicago

Stiller, Carl-Olav, and Paul Hjemdahl. 2022. “Lessons from 20 Years with COX-2 Inhibitors: Importance of Dose-Response Considerations and Fair Play in Comparative Trials.” Journal of Internal Medicine 292 (4): 557–74. doi:10.1111/joim.13505.